Cargando…

T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab

Many adverse reactions associated with immune checkpoint inhibitor (ICI) treatments are immunologically driven and may necessitate discontinuation of the ICI. Herein, we present a patient who had been administered the radio contrast media amidotrizoate multiple times without issue but who then devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammond, Sean, Olsson-Brown, Anna, Gardner, Joshua, Thomson, Paul, Ali, Serat-E, Jolly, Carol, Carr, Dan, Ressel, Lorenzo, Pirmohamed, Munir, Naisbitt, Dean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166637/ https://www.ncbi.nlm.nih.gov/pubmed/34049931 http://dx.doi.org/10.1136/jitc-2021-002521

Ejemplares similares

Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity
por: Hammond, Sean, et al.
Publicado: (2021)

Characterization of Drug-Specific CD4(+) T-Cells Reveals Possible Roles of HLA Class II in the Pathogenesis of Carbamazepine Hypersensitivity Reactions
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2023)

In-Vitro Approaches to Predict and Study T-Cell Mediated Hypersensitivity to Drugs
por: Hammond, Sean, et al.
Publicado: (2021)

Hypersensitivity Reactions to Iodinated Contrast Media
por: Chiu, Tsu-Man, et al.
Publicado: (2022)

Abs No: HLA-A*31:01 positive hypersensitive patient
por: Lichtenfels, Maike, et al.
Publicado: (2014)

Hypersensitivity Reactions to Multiple Iodinated Contrast Media
por: Doña, Inmaculada, et al.
Publicado: (2020)

Characterization of Teicoplanin-Specific T-Cells from Drug Naïve Donors Expressing HLA-A*32:01
por: Gardner, Joshua, et al.
Publicado: (2022)

Diagnosis and Prevention of Hypersensitivity Reactions to Iodinated Contrast Media
por: Kang, Hye-Ryun, et al.
Publicado: (2022)

Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01
por: Pratoomwun, Jirawat, et al.
Publicado: (2021)

Shared Clavulanate and Tazobactam Antigenic Determinants Activate T-Cells from Hypersensitive Patients
por: Ariza, Adriana, et al.
Publicado: (2022)

Drug Induced Hypersensitivity and the HLA Complex
por: Alfirevic, Ana, et al.
Publicado: (2010)

Pharmacological prevention of delayed hypersensitivity reactions caused by iodinated contrast media()
por: Kim, Jung-Hyun, et al.
Publicado: (2021)

Dapsone hypersensitivity syndrome
por: Zhao, Qing, et al.
Publicado: (2023)

Genome-wide association study of nevirapine hypersensitivity in a malawian HIV-infected population
por: Carr, Daniel, et al.
Publicado: (2014)

Immediate hypersensitivity reactions to IV non-ionic iodinated contrast in computed tomography
por: Ho, Jonathan, et al.
Publicado: (2012)

Oral premedication in patients with a history suggesting hypersensitivity to iodinated contrast media
por: Specjalski, Krzysztof, et al.
Publicado: (2020)

Immediate hypersensitivity reactions to iodinated contrast media: The diagnosis of allergy by skin testing
por: Caron, Juliette, et al.
Publicado: (2022)

Possible Iodine-Induced Thyrotoxicosis in a Previously Healthy Adolescent following Administration of Iodinated Contrast Media
por: Apsan, Jennifer, et al.
Publicado: (2021)

Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01
por: Ogese, Monday O, et al.
Publicado: (2021)

555 Frequency, Characteristics and Outcome of Immediate Hypersensitivity Reactions Due to Iodinated Contrast Media
por: Kampitak, Thatchai, et al.
Publicado: (2012)

The Potential Utility of Iodinated Contrast Media (ICM) Skin Testing in Patients with ICM Hypersensitivity
por: Ahn, Young-Hwan, et al.
Publicado: (2015)

Why drug exposure is frequently associated with T-cell mediated cutaneous hypersensitivity reactions
por: Line, James, et al.
Publicado: (2023)

CYP2B6*18 is associated with nevirpine hypersensitivity independently of HLA-C*04:01 in a Malawian HIV population
por: Carr, Daniel, et al.
Publicado: (2014)

Establishment of an HLA-typed cohort of 1000 healthy blood donors and use of a dendritic cell priming assay to prime naive T cells to structurally divergent drugs
por: Faulkner, Lee, et al.
Publicado: (2014)

Severe hypersensitivity reactions to iodinated contrast media: clinical and immunological features in a cohort of patients
por: Rivero Paparoni, Daniela, et al.
Publicado: (2014)

Skewing of the TCR V repertoire in SMX-NO specific T cell responses
por: Faulkner, Lee, et al.
Publicado: (2014)

New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity
por: Pirmohamed, Munir, et al.
Publicado: (2015)

Does immune checkpoint inhibitor therapy increase the frequency of adverse reactions to concomitant medications?
por: Hammond, Sean, et al.
Publicado: (2022)

Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Associations between HLA-A, -B, and -C alleles and iodinated contrast media–induced hypersensitivity in Koreans
por: Kim, Eun-Young, et al.
Publicado: (2021)

Pharmacological Prevention of Hypersensitivity Reactions Caused by Iodinated Contrast Media: A Systematic Review and Meta-Analysis
por: Hsieh, Chen, et al.
Publicado: (2022)

Characterization of amoxicillin and clavulanic-acid-responsive CD4+ And CD8+ T-cells in patients with co-amoxiclav-induced liver injury
por: Kim, Seung-Hyun, et al.
Publicado: (2014)

Identification of susceptible HLA class II co-amoxiclav genotypes based on the analysis of drug-specific T-cells from patients with liver injury
por: Saide, Katy, et al.
Publicado: (2014)

HLA-DQ restricted activation of nitroso-sulfamethoxazole-specific CD4+ T-lymphocytes
por: Ogese, Monday, et al.
Publicado: (2014)

Population Pharmacokinetic and Pharmacogenetic Analysis of Nevirapine in Hypersensitive and Tolerant HIV-Infected Patients from Malawi
por: Dickinson, Laura, et al.
Publicado: (2014)

Detection of interleukin-22 secreting T-cells in piperacillin hypersensitive patients with cystic fibrosis
por: Sullivan, Andrew, et al.
Publicado: (2014)

Antigen exposure required for T cell activation
por: Meng, Xiaoli, et al.
Publicado: (2014)

Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population
por: Carr, Daniel F., et al.
Publicado: (2013)

Pharmacologic and non-pharmacologic interventions to prevent hypersensitivity reactions of non-ionic iodinated contrast media: a systematic review protocol
por: Umakoshi, Hiroyasu, et al.
Publicado: (2020)

Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u3npbadhm3cnlepdd2s037blc0